Table 2.
Mean values of bone turnover markers of the two groups at baseline and 3 months of supplementation and comparisons between and within the groups.
| Group A | Group B | Between groups p-value | |
|---|---|---|---|
| P1NP baseline (mean ± SD) | 60.2 ± 15.6 | 59.1 ± 25.2 | 0.201 |
| P1NP at 3 months (mean ± SD) | 52 ± 15.1 | 57.1 ± 24.1 | 0.981 |
| Within group p-value | <0.001 | 0.210 | |
| P1NP % change from baseline to 3rd month (mean ± SD) | -13.1 ± 12.3 | -2.1 ± 12.6 | 0.011 |
| CTX baseline (mean ± SD) | 384 ± 107 | 418 ± 189 | 0.773 |
| CTX at 3 months (mean ± SD) | 333 ± 112 | 421 ± 210 | 0.382 |
| Within group p-value | 0.058 | 0.922 | |
| CTX % change from baseline to 3rd month (mean ± SD) | -11.4 ± 24 | 3.5 ± 29.9 | 0.079 |
P1NP, procollagen type I N-terminal propeptide; CTX, C-terminal telopeptide of collagen I. P1NP in ng/ml, CTX in pg/ml.